March 16th, 2021 – Medicinal Genomics Selects Soquimica as its Distribution Partner in Portugal Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparency of cannabis, today announced an agreement with Soquimica to be its distribution partner in Portugal.
August 20th, 2020 – Rose City Labs Adopts Medicinal Genomics’ qPCR Technology for Cannabis Testing Rose City Labs, a multistate state operating organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Portland, OR, facility, the first in that state.
July 30, 2020 – PharmLabs, First Hemp Lab in Texas, Selects Medicinal Genomics for Microbial Testing Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety and transparency of cannabis, today announced that PharmLabs, a multistate testing lab organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Texas hemp lab, the first in that state.
May 05, 2020 – Medicinal Genomics to Launch Medical Practicum at CannMed 2020 The biggest barrier to using medicinal cannabis is that the endocannabinoid system and its related pathologies are not taught in medical school, and as a result, physicians cannot help their patients use cannabis as an effective and safe medication
April 2, 2020 – Medicinal Genomics to Donate a Portion of CannMed Tickets Sales to COVID-19 Response Premier medical & scientific cannabis conference to contribute 10% of ticket sales to support CDC Emergency Response Fund to help mitigate the public health threat
March 10, 2020 – Medicinal Genomics Signs on as Agilent US Value Added Reseller MGC will sell Agilent’s Aria qPCR instruments and Bravo, Agilent’s liquid handling DNA purification and lab automation platform in the U.S
March 9, 2020 – Revolutionizing cannabis cultivation with world-first SNP chip The SNP chip will serve as a powerful research tool for cannabis cultivation, enabling more discoveries of quantitative traits and expanding the diversity of cannabis cultivars assessed in genetic prediction.
February 27, 2020 – Medicinal Genomics Announces New PathoSEEK® Aspergillus Multiplex Assay to Streamline Cannabis Testing New 5-color assay independently identifies four species of pathogenic Aspergillus plus a cannabis control in just one qPCR reaction
January 30, 2020 – Medicinal Genomics Expands Global Reach with Distribution Partners in South America and Southeast Asia Leading genomics firm driving adoption of biotechnology to improve cannabis production in geographies around the world